Toggle light / dark theme

Stem cell research may be controversial but it’s showing incredible promise in treating a number of long-incurable diseases. The latest target for scientists working with stem cells is type 1 diabetes, and a new study reveals that it’s possible to convert stem cells into cells capable of producing insulin, potentially opening the door to a cure.

The goal which the scientists are rapidly working towards is to be able to replace insulin-producing cells in individuals who have type 1 diabetes. In diabetes patients those cells are often destroyed when the person is young, requiring that they monitor their blood sugar levels and take insulin to manage the disease.

Read more

Great news!


Inspired by British billionaire Jim Mellon, chairman of anti-aging upstart biotech venture Juvenescence, Sergey Young unveiled a $100 million fund on Monday to catalyze the development of a comprehensive solution to counteract the damaging consequences of aging.

“I’ve never looked like my age…and with my name, I think it was predetermined that I was going to work in the space (of aging),” Young told Endpoints News. The 47-year-old considers himself a product of Peter Diamandis — the man behind the non-profit XPRIZE and venture capital fund BOLD Capital Partners — and is in charge of all things longevity at both organizations.

Read more

Longevity Investor Network member Sebastian Aguiar discusses the rejuvenation biotechnology industry and bridging the gap between research and development.


Sebastian Aguiar is a Venture Fellow at Apollo Ventures, an aging-focused venture capital fund and company builder that invests across Europe and the United States. He can be found at https://www.linkedin.com/in/sebastianaguiar/ and https://twitter.com/sebastian_gero.

What initially attracted you to aging as a general discipline?

Aging is already a solved problem… for cells. The germ line is immortal. Cancer cells are immortal as well. In fact, cellular immortality has been a solved problem for 3.5 billion years, since the dawn of life on Earth. It’s just that the soma – all the cells other than the reproductive cells – are disposable.

Despite unbelievable advances in medical science in recent decades, breast cancer kills. Approximately 1 in 8 American women will develop breast cancer cells during the course of their lifetime.

Finding a cure is imperative, and as such, fervent research continues. At the European Breast Cancer Conference in Amsterdam, scientists presented a pair of drugs with an astounding claim: this treatment can eradicate some types of breast cancer in only 11 days, eliminating the need for chemotherapy.

Chemotherapy, whilst an amazing feat of medical-scientific engineering, is known for its uncomfortable and sometimes debilitating side effects. Women undergoing chemotherapy for breast cancer treatment may lose their hair, suffer extreme fatigue, and even loss of cognitive function.

Read more